Literature DB >> 235612

The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine.

J E Blundell, M B Leshem.   

Abstract

5-Hydroxytryptophan (5-HTP), amphetamine and fenfluramine suppressed food intake in normal rats and in aminals with lesions of the lateral hypothalamus. The anorexic effect of amphetamine was reduced in lesioned animals compared with controls while the effect of 5-HTP like that of fenfluramine was increased. When administered in conjunction with anorexic drugs, 5-HTP markedly potentiated the anorexic effect of amphetamine in both control and lesioned animals. However, 5-HTP potentiated fenfluramine anorexia only in lesioned rats. These findings provide further evidence for the role of 5-hydroxytryptamine (5-HT,in the anorexic effect of fenfluramine, and suggest that a 5-HT mechanism, inhibitory for feeding, produces particulary severe suppression of food intake in rats with lateral hypothalamic lesions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235612     DOI: 10.1111/j.2042-7158.1975.tb09374.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  13 in total

Review 1.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

2.  The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.

Authors:  F Ceci; C Cangiano; M Cairella; A Cascino; M Del Ben; M Muscaritoli; L Sibilia; F Rossi Fanelli
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

3.  Sensitivity of the behavioural assay for measuring the action of drugs on feeding: effects of tryptophan and 5-hydroxy-tryptophan [proceedings].

Authors:  J E Blundell; C J Latham
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

4.  Fluoxetine suppresses palatability-induced ingestion.

Authors:  J D Leander
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

6.  Clinical pharmacological studies of tandamine, a potential antidepressive drug.

Authors:  R S Ehsanullah; K Ghose; M J Kirby; P Turner; D Witts
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

7.  Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.

Authors:  C T Dourish; P H Hutson; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 8.  Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.

Authors:  Elizabeth K Nousen; Juliana G Franco; Elinor L Sullivan
Journal:  Neuroendocrinology       Date:  2013-09-21       Impact factor: 4.914

9.  Alteration of the disruptive effect of fenfluramine on food consumption in the rat by repeated post-session administration of d-amphetamine.

Authors:  R N Hunsinger; T B Barnes; J C Kapeghian; M C Wilson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies.

Authors:  Fabio Panariello; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Schizophr Res Treatment       Date:  2010-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.